Hosein Kouros Mehr
About Hosein Kouros Mehr
Hosein Kouros Mehr serves as the Vice President of Hematology/Oncology at Sana Biotechnology, Inc. He has extensive experience in the biotechnology and pharmaceutical industries, having held various roles at companies such as Amgen, Eli Lilly, and Genentech.
Current Role at Sana Biotechnology
Hosein Kouros Mehr serves as the Vice President of Hematology/Oncology at Sana Biotechnology, Inc. He has held this position since 2021. In this role, he focuses on advancing therapeutic strategies in hematology and oncology, contributing to the company's mission of developing innovative treatments.
Previous Experience at Amgen
Before joining Sana Biotechnology, Hosein Kouros Mehr worked at Amgen in various capacities. He served as Medical Director from 2018 to 2021, overseeing medical strategies for hematology and oncology products. He briefly held the position of Executive Medical Director in 2021 for four months, further enhancing his leadership experience in the biopharmaceutical sector.
Educational Background
Hosein Kouros Mehr completed his Doctor of Medicine (M.D.) degree at the University of California, San Francisco, from 2001 to 2008. He also earned a Doctor of Philosophy (PhD) in Biomedical Sciences from the same institution, studying from 2003 to 2006. His foundational education includes a Bachelor of Science (B.S.) in Biology from the California Institute of Technology, completed from 1997 to 2000.
Career History in Oncology and Hematology
Hosein Kouros Mehr has extensive experience in oncology and hematology research. He worked as a Senior Scientist at Agensys, Inc. from 2014 to 2017, and as a Research Scientist at Eli Lilly and Company from 2012 to 2014. His early career included roles at the National Cancer Institute as a Post-doctoral Fellow and at Genentech as an Associate Scientist.